Purchase of common stock, 2025 Pre-Funded Warrants and 2025 Common Warrants in the 2025 Private Placement.
| Officer | Age | In this role | Joined | 2026 pay | Source |
|---|---|---|---|---|---|
|
Prashant Kohli
Also a director
Chief Executive Officer
|
54 | Not stated | Not stated | $1,270,820 | |
|
Robert DelAversano
Principal Financial Officer
Title from the Form 4 dated Aug 28, 2026
|
55 | Not stated | 2023 | Not reported | |
|
R. Loch Macdonald
Chief Medical Officer
|
65 |
Since 2023
3 years
|
Not stated | Not reported | |
|
Amresh Kumar
Vice President, Program Management
|
47 |
Since 2023
3 years
|
Not stated | $465,650 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Purchase of common stock, 2025 Pre-Funded Warrants and 2025 Common Warrants in the 2025 Private Placement.
Purchase of common stock, 2025 Pre-Funded Warrants and 2025 Common Warrants in the 2025 Private Placement; the stated gross proceeds are an aggregate for all related parties in the placement.
Loading...